Please provide your email address to receive an email when new articles are posted on . Continuous cough monitoring allows for assessment of immediate treatment effects in patients with refractory ...

For over 60 years, the search for an effective pharmacologic treatment for refractory or unexplained chronic cough has been ...

Chronic cough took center stage at the European Respiratory Society (ERS) Congress session titled "Conditions We Are Just Dealing With the Tip of the Iceberg in Primary Care: Frequently Mismanaged ...

From December 4 to 6, 2025, the 5th International Cough Conference (ICC) was successfully held in Guangzhou, China. This ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Some people continue coughing after they recover from a common respiratory infection. Doctors explain why a cough can last ...

A drug Merck is developing for chronic cough failed to win over a panel of advisors to the Food and Drug Administration on Friday, making approval unlikely. The FDA’s Pulmonary-allergy Drugs Advisory ...

The combined impact of respiratory illness such as COPD, asthma, chronic cough and pneumonia on individuals and health systems is staggering. COPD alone affects more than 15 million people and costs ...

Add Yahoo as a preferred source to see more of our stories on Google. Even if it's not accompanied by other symptoms, battling an ongoing cough can be annoying. Whether you’re coughing constantly or ...

Chronic cough is among the most common reasons for seeking medical care, with middle-aged women the group most affected. New studies also show that this condition appears to be a hereditary phenomenon ...

The FDA declined to approve oral gefapixant for treating chronic cough, Merck announced on Wednesday. In its complete response letter, "the FDA concluded that Merck's application did not meet ...